Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.

Documenti analoghi

• Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication.
  di: Lin, J C, et al.
  Pubblicazione: (1987)
• Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
  di: Smith, M S, et al.
  Pubblicazione: (1993)
• Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.
  di: Lin, J C, et al.
  Pubblicazione: (1988)
• Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
  di: Spector, S A, et al.
  Pubblicazione: (1989)
• Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages.
  di: Szebeni, J, et al.
  Pubblicazione: (1989)